1. Lung cancer diagnosis from proteomic analysis of preinvasive lesions. Rahman SM, Gonzalez AL, Li M, Seeley EH, Zimmerman LJ, Zhang XJ, Manier ML, Olson SJ, Shah RN, Miller AN, Putnam JB, Miller YE, Franklin WA, Blot WJ, Carbone DP, Shyr Y, Caprioli RM, Massion PP (2011) Cancer Res 71(8): 3009-17
    › Primary publication · 21487035 (PubMed) · PMC3110721 (PubMed Central)
  2. High-throughput quantification of bioactive lipids by MALDI mass spectrometry: application to prostaglandins. Manna JD, Reyzer ML, Latham JC, Weaver CD, Marnett LJ, Caprioli RM (2011) Anal Chem 83(17): 6683-8
    › Primary publication · 21770391 (PubMed) · PMC3165080 (PubMed Central)
  3. Structural characterization of phospholipids and peptides directly from tissue sections by MALDI traveling-wave ion mobility-mass spectrometry. Ridenour WB, Kliman M, McLean JA, Caprioli RM (2010) Anal Chem 82(5): 1881-9
    › Primary publication · 20146447 (PubMed) · PMC2830338 (PubMed Central)
  4. Structural and functional characterization of the monomeric U-box domain from E4B. Nordquist KA, Dimitrova YN, Brzovic PS, Ridenour WB, Munro KA, Soss SE, Caprioli RM, Klevit RE, Chazin WJ (2010) Biochemistry 49(2): 347-55
    › Primary publication · 20017557 (PubMed) · PMC2806929 (PubMed Central)
  5. Proteomic analysis of osteogenic sarcoma: association of tumour necrosis factor with poor prognosis. Cates JM, Friedman DB, Seeley EH, Dupont WD, Schwartz HS, Holt GE, Caprioli RM, Young PP (2010) Int J Exp Pathol 91(4): 335-49
    › Primary publication · 20353421 (PubMed) · PMC2962892 (PubMed Central)
  6. Molecular imaging by mass spectrometry--looking beyond classical histology. Schwamborn K, Caprioli RM (2010) Nat Rev Cancer 10(9): 639-46
    › Primary publication · 20720571 (PubMed)
  7. Molecular analysis of tumor margins by MALDI mass spectrometry in renal carcinoma. Oppenheimer SR, Mi D, Sanders ME, Caprioli RM (2010) J Proteome Res 9(5): 2182-90
    › Primary publication · 20141219 (PubMed) · PMC2866033 (PubMed Central)
  8. MALDI imaging mass spectrometry--painting molecular pictures. Schwamborn K, Caprioli RM (2010) Mol Oncol 4(6): 529-38
    › Primary publication · 20965799 (PubMed) · PMC2981679 (PubMed Central)
  9. Identification of markers of taxane sensitivity using proteomic and genomic analyses of breast tumors from patients receiving neoadjuvant paclitaxel and radiation. Bauer JA, Chakravarthy AB, Rosenbluth JM, Mi D, Seeley EH, De Matos Granja-Ingram N, Olivares MG, Kelley MC, Mayer IA, Meszoely IM, Means-Powell JA, Johnson KN, Tsai CJ, Ayers GD, Sanders ME, Schneider RJ, Formenti SC, Caprioli RM, Pietenpol JA (2010) Clin Cancer Res 16(2): 681-90
    › Primary publication · 20068102 (PubMed) · PMC2892225 (PubMed Central)
  10. Detection of tumor epidermal growth factor receptor pathway dependence by serum mass spectrometry in cancer patients. Chung CH, Seeley EH, Roder H, Grigorieva J, Tsypin M, Roder J, Burtness BA, Argiris A, Forastiere AA, Gilbert J, Murphy B, Caprioli RM, Carbone DP, Cohen EE (2010) Cancer Epidemiol Biomarkers Prev 19(2): 358-65
    › Primary publication · 20086114 (PubMed) · PMC2846615 (PubMed Central)